Study of the MicroRNA Expression Profile of Foreskin Derived Mesenchymal Stromal Cells Following Inflammation Priming

Overview

Journal J Transl Med

Publisher Biomed Central

Specialties Biomedical Engineering
General Medicine

Date 2017 Jan 15

PMID 28086811

Citations 9

Authors

Hussein Fayyad-Kazan

Mohammad Fayyad-Kazan

Bassam Badran

Dominique Bron

Laurence Lagneaux

Mehdi Najar

Affiliations

Soon will be listed here.

Abstract

Background: Due to their self-renewal capacity, multi-lineage potential, and immunomodulatory properties, mesenchymal stromal cells (MSCs) are an attractive tool for different therapeutic strategies. Foreskin (FSK), considered as a biological waste material, has already been shown to be a valuable source of MSCs. Besides their typical fibroblast like morphology and International Society for cellular Therapy compliant phenotype, foreskin-MSCs (FSK-MSCs) are clonogenic, and highly proliferative cells with multi-lineage and strong immunomodulatory capacities. Of importance, FSK-MSCs properly adjust their fate following exposure to inflammatory signals. Being potent regulators of gene expression, miRNAs are involved in modulating nearly all cellular processes and in orchestrating the roles of different immune cells. In this study, we characterized the miRNome of FSK-MSCs by determining the expression profile of 380 different miRNAs in inflammation primed vs. control non-primed cells.

Methods: TaqMan low density array (TLDA) was performed to identify dysregulated miRNAs after exposing FSK-MSCs to inflammatory signals. Quantitative real-time RT-PCR was carried out to validate the observations. DIANA-miRPath analysis web server was used to identify potential pathways that could be targeted by the dysregulated miRNAs.

Results: Sixteen miRNAs were differentially expressed in inflammation-primed vs. non-primed FSK-MSCs. The expression level of miR-27a, -145, -149, -194, -199a, -221, -328, -345, -423-5p, -485-3p, -485-5p, -615-5p and -758 was downregulated whilst that of miR-155, -363 and -886-3p was upregulated. Target pathway prediction of those differentially expressed miRNAs identified different inflammation linked pathways.

Conclusions: After determining their miRNome, we identified a striking effect of inflammatory signals on the miRNAs' expression levels in FSK-MSCs. Our results highlight a potential role of miRNAs in modulating the transcription programs of FSK-MSCs in response to inflammatory signals. Further, we propose that specific miRNAs could serve as interesting targets to manipulate some functions of FSK-MSCs, thus ameliorating their therapeutic potential.

Citing Articles

Role of Mesenchymal Stem Cells and Their Paracrine Mediators in Macrophage Polarization: An Approach to Reduce Inflammation in Osteoarthritis.

Kuppa S, Kim H, Kang J, Lee S, Seon J Int J Mol Sci. 2022; 23(21).

PMID: 36361805 PMC: 9658630. DOI: 10.3390/ijms232113016.

Analysis of MicroRNA Profile Alterations in Extracellular Vesicles From Mesenchymal Stromal Cells Overexpressing Stem Cell Factor.

Zubkova E, Evtushenko E, Beloglazova I, Osmak G, Koshkin P, Moschenko A Front Cell Dev Biol. 2021; 9:754025.

PMID: 34869342 PMC: 8634878. DOI: 10.3389/fcell.2021.754025.

miR-155 Contributes to the Immunoregulatory Function of Human Mesenchymal Stem Cells.

Pers Y, Bony C, Duroux-Richard I, Bernard L, Maumus M, Assou S Front Immunol. 2021; 12:624024.

PMID: 33841404 PMC: 8033167. DOI: 10.3389/fimmu.2021.624024.

Bioengineering Approaches to Accelerate Clinical Translation of Stem Cell Therapies Treating Osteochondral Diseases.

Wang M, Luo Y, Yu Y, Chen F Stem Cells Int. 2021; 2020:8874742.

PMID: 33424981 PMC: 7775142. DOI: 10.1155/2020/8874742.

Mesenchymal Stromal Cell-Based Therapy: New Perspectives and Challenges.

Najar M, Bouhtit F, Melki R, Afif H, Hamal A, Fahmi H J Clin Med. 2019; 8(5).

PMID: 31071990 PMC: 6572531. DOI: 10.3390/jcm8050626.

References

He H, Jazdzewski K, Li W, Liyanarachchi S, Nagy R, Volinia S . The role of microRNA genes in papillary thyroid carcinoma. Proc Natl Acad Sci U S A. 2005; 102(52):19075-80. PMC: 1323209. DOI: 10.1073/pnas.0509603102. View

Martinez-Sanchez A, Dudek K, Murphy C . Regulation of human chondrocyte function through direct inhibition of cartilage master regulator SOX9 by microRNA-145 (miRNA-145). J Biol Chem. 2011; 287(2):916-24. PMC: 3256897. DOI: 10.1074/jbc.M111.302430. View

Taganov K, Boldin M, Chang K, Baltimore D . NF-kappaB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses. Proc Natl Acad Sci U S A. 2006; 103(33):12481-6. PMC: 1567904. DOI: 10.1073/pnas.0605298103. View

Haramati S, Chapnik E, Sztainberg Y, Eilam R, Zwang R, Gershoni N . miRNA malfunction causes spinal motor neuron disease. Proc Natl Acad Sci U S A. 2010; 107(29):13111-6. PMC: 2919953. DOI: 10.1073/pnas.1006151107. View

Sonkoly E, Pivarcsi A . Advances in microRNAs: implications for immunity and inflammatory diseases. J Cell Mol Med. 2009; 13(1):24-38. PMC: 3823034. DOI: 10.1111/j.1582-4934.2008.00534.x. View

Hassan M, Gordon J, Beloti M, Croce C, van Wijnen A, Stein J . A network connecting Runx2, SATB2, and the miR-23a~27a~24-2 cluster regulates the osteoblast differentiation program. Proc Natl Acad Sci U S A. 2010; 107(46):19879-84. PMC: 2993380. DOI: 10.1073/pnas.1007698107. View

Giai Via A, Frizziero A, Oliva F . Biological properties of mesenchymal Stem Cells from different sources. Muscles Ligaments Tendons J. 2013; 2(3):154-62. PMC: 3666517. View

Livak K, Schmittgen T . Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 2002; 25(4):402-8. DOI: 10.1006/meth.2001.1262. View

Chan C, Kay L, Khadaroo R, Chan M, Lakatoo S, Young K . Soluble fibrinogen-like protein 2/fibroleukin exhibits immunosuppressive properties: suppressing T cell proliferation and inhibiting maturation of bone marrow-derived dendritic cells. J Immunol. 2003; 170(8):4036-44. DOI: 10.4049/jimmunol.170.8.4036. View

10.

Clark E, Kalomoiris S, Nolta J, Fierro F . Concise review: MicroRNA function in multipotent mesenchymal stromal cells. Stem Cells. 2014; 32(5):1074-82. PMC: 10668871. DOI: 10.1002/stem.1623. View

11.

Schmittgen T, Livak K . Analyzing real-time PCR data by the comparative C(T) method. Nat Protoc. 2008; 3(6):1101-8. DOI: 10.1038/nprot.2008.73. View

12.

El Omar R, Beroud J, Stoltz J, Menu P, Velot E, Decot V . Umbilical cord mesenchymal stem cells: the new gold standard for mesenchymal stem cell-based therapies?. Tissue Eng Part B Rev. 2014; 20(5):523-44. DOI: 10.1089/ten.TEB.2013.0664. View

13.

Liu Z, Sall A, Yang D . MicroRNA: An emerging therapeutic target and intervention tool. Int J Mol Sci. 2009; 9(6):978-999. PMC: 2658779. DOI: 10.3390/ijms9060978. View

14.

Zaroo M, Sheikh B, Wani A, Darzi M, Mir M, Dar H . Use of preputial skin for coverage of post-burn contractures of fingers in children. Indian J Plast Surg. 2011; 44(1):68-71. PMC: 3111128. DOI: 10.4103/0970-0358.81436. View

15.

da Silva Meirelles L, Maria Fontes A, Covas D, Caplan A . Mechanisms involved in the therapeutic properties of mesenchymal stem cells. Cytokine Growth Factor Rev. 2009; 20(5-6):419-27. DOI: 10.1016/j.cytogfr.2009.10.002. View

16.

Najar M, Raicevic G, Fayyad-Kazan H, Kazan H, De Bruyn C, Bron D . Immune-related antigens, surface molecules and regulatory factors in human-derived mesenchymal stromal cells: the expression and impact of inflammatory priming. Stem Cell Rev Rep. 2012; 8(4):1188-98. DOI: 10.1007/s12015-012-9408-1. View

17.

Miller B, Wahlestedt C . MicroRNA dysregulation in psychiatric disease. Brain Res. 2010; 1338:89-99. PMC: 2891055. DOI: 10.1016/j.brainres.2010.03.035. View

18.

Cloonan N, Brown M, Steptoe A, Wani S, Chan W, Forrest A . The miR-17-5p microRNA is a key regulator of the G1/S phase cell cycle transition. Genome Biol. 2008; 9(8):R127. PMC: 2575517. DOI: 10.1186/gb-2008-9-8-r127. View

19.

Collino F, Bruno S, Deregibus M, Tetta C, Camussi G . MicroRNAs and mesenchymal stem cells. Vitam Horm. 2011; 87:291-320. DOI: 10.1016/B978-0-12-386015-6.00033-0. View

20.

Loza M, McCall C, Li L, Isaacs W, Xu J, Chang B . Assembly of inflammation-related genes for pathway-focused genetic analysis. PLoS One. 2007; 2(10):e1035. PMC: 2001184. DOI: 10.1371/journal.pone.0001035. View